Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Rating of "Hold" from Analysts

Key Points

• Analysts have a mixed view of Aspen Aerogels: seven brokerages give the stock an average “Hold” rating, with two sells, one hold and four buys. The average 12-month price target is $5.94.
• A major shareholder sold a substantial stake: Wood River Capital sold 12.28 million shares for approximately $58.1 million at an average price of $4.73. Insiders own 2.96% of the company, while institutions and hedge funds hold 97.64%.
• Aspen Aerogels reported a quarterly loss of $0.22 per share, slightly better than estimates, while revenue of $49.85 million exceeded expectations. Despite the revenue beat, the company remains unprofitable and analysts expect a full-year loss of $0.69 per share.

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have earned an average rating of "Hold" from the seven brokerages that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $5.94.

ASPN has been the topic of several research reports. Barclays raised their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research report on Tuesday, August 11th. B. Riley Financial reissued a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Wall Street Zen downgraded shares of Aspen Aerogels from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a research report on Monday, September 21st. Finally, Roth Capital reaffirmed a "buy" rating and set a $7.75 price target on shares of Aspen Aerogels in a report on Friday, August 7th.

Insider Buying and Selling at Aspen Aerogels

In other news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.96% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

A number of institutional investors have recently made changes to their positions in the business. Concurrent Investment Advisors LLC raised its stake in Aspen Aerogels by 6.7% during the second quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company's stock valued at $203,000 after buying an additional 2,000 shares in the last quarter. Royal Bank of Canada boosted its holdings in Aspen Aerogels by 95.8% in the first quarter. Royal Bank of Canada now owns 8,523 shares of the construction company's stock worth $29,000 after purchasing an additional 4,169 shares during the period. Legal & General Group Plc acquired a new position in Aspen Aerogels in the second quarter worth $44,000. Clarus Group Inc. bought a new stake in Aspen Aerogels during the first quarter valued at $36,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in Aspen Aerogels during the fourth quarter valued at $30,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Up 2.9%

ASPN opened at $5.86 on Wednesday. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.35. The firm has a 50 day moving average price of $5.27 and a 200 day moving average price of $4.99. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52. The company has a market cap of $485.91 million, a PE ratio of -3.83 and a beta of 3.06.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Sell-side analysts expect that Aspen Aerogels will post -0.69 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc develops and manufactures advanced aerogel-based materials designed to provide thermal management, insulation and fire protection. The company's products are used in applications where low weight, energy efficiency and resistance to heat are important, serving industries including electric vehicles, energy infrastructure, industrial processing and building materials.

Its product portfolio includes PyroThin thermal barriers for lithium-ion battery systems, as well as aerogel insulation products such as Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.